Delcath Systems Inc (DCTH)

[SAMNOTSAMUEL]

You should concede that crossover lived 100 days longer than the pure CS arm plus the gen 1 filter replacement was seen as an additional problem and the need for gen 2 improvement which was not tested at all in the phase 3 … AND A 16 to 0 vote against. Bottom line is this company should be treated as brand new on the day this gen 2 trial result is released to the public. Safety improvement should then be reviewed, number of treatments per patient will be of great interest, etc..